Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 公司主营业务为生物制药及中成药的研发、生产和销售,辅以房地产开发、物业管理和服务等业务。公司经过多年的产业布局和研发投入,医药产品覆盖创新基因工程制药、新型疫苗、现代中药等多个医药细分领域,是公司业绩的主要来源。房地产业务进行有计划的土地储备,立足特色地产开发与经营。 | ||||||||||||||||||||||||
Main Business | 生物制药及中成药的研发、生产和销售,辅以房地产开发、物业管理和服务等业务。 | ||||||||||||||||||||||||
Legal Representative | 姜云涛 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 李洪谕 | ||||||||||||||||||||||||
Solicitors | 北京市康达律师事务所 | ||||||||||||||||||||||||
Auditors | 大信会计师事务所(特殊普通合伙);普华永道中天会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 0431-80557027 | ||||||||||||||||||||||||
Fax No | 0431-80557027 | ||||||||||||||||||||||||
Website | ccht.jl.cn | ||||||||||||||||||||||||
000661@ccht.jl.cn;zds@ccht.jl.cn | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 18/12/1996 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 11.210 | ||||||||||||||||||||||||
DPS(RMB)* | ¥ 4.500 | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 54.552 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 36.729B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |